The global Ablation Devices Market is slated to top USD 4.4 Billion in 2023. Expanding at a healthy 11.1% CAGR, the market size is projected to total USD 12.6 Billion by 2033.
Here are a few factors which are expected to contribute to further growth in the said forecast period:
| Attribute | Details |
|---|---|
| Ablation Devices Market Estimated Size 2023 | USD 4.4 Billion |
| Ablation Devices Market Value-based CAGR (2023 to 2033) | ~ 11.1% |
| Ablation Devices Market Size in Projected 2033 | USD 12.6 Billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Ablation devices offer minimally invasive procedures, which are less painful than traditional surgical procedures. Hence the recovery time is also shorter. The damage incurred to the surrounding tissues shall also be minimal. This has bolstered consumer preference for the product.
The application of ablation Devices for large and bulky tissues isn’t possible currently. This includes sensitive areas such as the bone and neck nodules. Ablation treatment is yet to garner wide availability in remote locations. Hence, many patients belonging to low-income groups could have restricted access to ablation treatments.
Principal Consultant
Globally, surgical procedures have undergone major transformations. From incorporating technologically adept screening, diagnostic, and treatment equipment to approaches that ensure little to no post-surgical trauma, the healthcare industry has experienced significant developments.
One such advancement is the advent of minimally invasive surgery. Given the expanding geriatric population pool and the complicating nature of chronic disorders, patients are seeking treatment options that are not too intrusive to their well-being.
Minimally invasive surgeries are attributed to less pain, shorter hospital stays, and faster recovery. Ablation is also a part and parcel of minimally invasive surgery. Ablation is the removal of biological material from human organs by vaporization, cryo treatment, radiation procedures, chipping, or other erosive processes.
In the medical sector, ablation is performed usually through surgical methods for the removal of biological substances i.e., usually a small tumor. Other techniques adopted for the removal of infected biological tissues include chemical ablation and radiofrequency ablation.
In the recent past, ablation has received immense popularity, owing to its minimally invasive nature of removal of tumors and tissues with a bearable painless recovery period than that of open surgical procedures. Demand for ablation devices is expected to increase owing to the increasing incidence of chronic diseases, mainly tumorigenic cancer, and other cardiovascular disorders, across the globe.
Ablation is expected to find extensive applications in the oncology sector. It was estimated that 18.1 million cancer cases were diagnosed as of 2020. Breast and lung cancers were the most common cancers globally, comprising 12.5% and 12.2% of total incidence rates.
Hence, medical practitioners and surgeons have been working tirelessly to develop breakthroughs and reduce this global burden. Cancer eradication remains a major challenge in the 21st century.
Cancer ablation is a minimally invasive surgical procedure to treat solid cancers. Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US), or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within cancer it is attached to a generator which “burns” or “freezes” cancer.
Most patients have this procedure without anesthesia, only conscious sedation. More than 90% of patients are released from the hospital the day after the procedure. Recent advancements have seen the increased deployment of pulsed electric field ablation, which has especially revolutionized cancer treatment.
Leading players operating in the global ablation devices market are currently focusing on conducting exhaustive research and development activities to introduce state-of-the-art products to cater to the high demand from healthcare professionals and patients.
Meanwhile, some of the other key players are aiming to achieve patents from regulatory bodies for their in-house thermal ablation machines to market them and generate more sales.
The increasing adoption of ablation machines across various medical domains, such as cardiovascular, gynecology, cancer, and ophthalmology, to treat several diseases is projected to drive sales in this market. Unlike conventional surgical operations, ablation therapy is less painful and is a minimally invasive procedure that requires a shorter hospital stay and quick recovery time.
Thermal ablation machines can lower or eliminate the unpleasant symptoms of atrial fibrillation, such as weakness, fatigue, and shortness of breath. It also causes very little damage to the surrounding tissues and thus, is expected to gain momentum in the upcoming years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Particulars | Details |
|---|---|
| H1, 2022 | 10.97% |
| H1, 2023 Projected | 11.30% |
| H1, 2023 Outlook | 10.80% |
| BPS Change - H1, 2023 (O) - H1, 2023 (P) | (-) 50 ↓ |
| BPS Change - H1, 2023 (O) - H1, 2022 | (-) 17 ↓ |
According to Future Market Insight analysis, the global ablation devices market expects to drop by 17 Basis Point Share (BPS) in H1-2023 as compared to H1- 2022. Whereas, in comparison to the H1-2023 Projected value, the market during the H1-2022 outlook period will show a dip of 50 BPS.
Due to an increase in FDA recalls, the market for ablation devices is anticipated to grow more slowly than expected. For instance, the US FDA recalled the Boston Scientific Corporation-produced Cardiac Ablation Percutaneous Catheter in November 2018 as a Class 3 Device Recall due to the supplier's three unannounced resin sub-supplier changes. This is a prime factor responsible for the reduction in the BPS values.
Conversely, the development of new ablation tools, such as CF-sensing catheters or novel balloon devices has gained adoption and will promote the growth of the market throughout the forecasted years. A key development in the market includes the usage of radiofrequency ablation to treat chronic pain.
The ablation devices market is expected to register an 11.1% CAGR between 2023 and 2033, up from the 9.8% CAGR recorded from 2017 to 2022, predicts Future Market Insights.
The increasing number of awareness programs conducted by government bodies to educate the masses regarding the benefits of using ablation machines is a primary factor driving the market. The launch of several cutting-edge machines by renowned manufacturers also will create prospects for growth.
In November 2020, for instance, Abbott announced the launch of a new radiofrequency ablation device named IonicRF Generator. It was cleared by the United States Food and Drug Administration (FDA) to provide a minimally invasive and non-surgical treatment for the management of pain in the nervous system.
It utilizes heat to block pain signals from reaching the brain by targeting specific nerves. The launch of similar other unique devices by key players is expected to accelerate the growth in this market.
Short term (2023 to 2026): The increasing number of cases of cancer is estimated to propel the demand for radiofrequency ablation devices in the initial phase. According to the World Health Organization (WHO), in 2022, approximately 10 million deaths occurred globally because of cancer. The surging prevalence of cancer across the globe is a major factor that is anticipated to bolster the market.
Medium Term (2026 to 2029): The need for cardiac ablation devices could spur during this phase. This growth is attributable to the rising cases of cardiac arrest worldwide owing to the increasing prevalence of coronary artery disease, high blood pressure, diabetes, inactive lifestyle, smoking, and high blood cholesterol. As per the WHO, nearly 17.9 million people died from Cardiovascular Diseases (CVDs) worldwide, and out of these deaths, 85% were due to stroke and heart attack.
The organization also declared that evidence from around 18 countries demonstrated that the implementation of cost-effective hypertension programs at the primary care level can reduce the cases of stroke and coronary heart disease. Driven by the above-mentioned factors, the market is likely to grow at a rapid pace in the mid-term phase.
Long Term (2029 to 2033): The long-term growth prospects of the market are largely reliant on technological advancement in the field. Embedding advanced technologies in key product variants would enhance precision and efficiency. This could enable better market penetration, bolstering the current consumer base.
Market bottlenecks such as lack of product availability could be greatly ameliorated through technological advancement. These would make the product not only more consumer-centric but also feasible for wide-scale production.
During the current forecast period, the market is expected to grow at a CAGR of 11.1%.
Ablation Devices Market:
| Attributes | Ablation Devices Market |
|---|---|
| CAGR (2023 to 2033) | 11.1% |
| Market Value (2033) | USD 12.6 Billion |
| Growth Factor | The rise in the prevalence of cancer, and cardiovascular diseases as well as consumer preference for minimally invasive procedures over traditional surgical procedures |
| Opportunity | Making the product widely available could carve out a larger application base for the product |
| Key Trends | Both healthcare providers are opting for ablation devices due to the plethora of product benefits and rising awareness |
Photodynamic Therapy Market:
| Attributes | Photodynamic Therapy Market |
|---|---|
| CAGR (2023 to 2033) | 8.5% |
| Market Value (2033) | USD 38.5 Billion |
| Growth Factor | An increase in incidences of cancer, as well as diseases in the geriatric population, and the rapid rise of skin disorders are positively impacting the market growth. |
| Opportunity | Training more skilled personnel, under the initiative of key players could significantly improve market prospects |
| Key Trends | Developed markets such as Europe and North America are anticipated to be lucrative for investors during the forecast period. |
Spectacles Market:
| Attributes | Spectacles Market |
|---|---|
| CAGR (2023 to 2033) | 7.5% |
| Market Value (2033) | USD 213.5 Billion |
| Growth Factor | Consumer preference for minimally invasive procedures, rising incidences of skin disorders and other chronic conditions, application of cryotherapy in different types of wellness centers |
| Opportunity | As the treatment gains attention as a beauty-enhancing therapy, a lucrative market could emerge in the cosmetic segment |
| Key Trends | There is a rise in the number of wellness/fitness centers using cryotherapy globally |
Mergers and Acquisitions between Key Players to Boost Sales of Cardiac Ablation Devices
The rising number of mergers and acquisitions between leading players and start-up companies present in the United States is set to drive the North American ablation devices market growth. This strategy would help them to broaden their existing product portfolios and attract more customers.
In January 2022, for instance, Medtronic acquired Affera Inc., a Boston-based medical technology company. This acquisition would enable the former to expand its presence in the mapping and ablation navigation system market by including the latter’s catheter-based cardiac ablation technologies. Driven by the aforementioned factors, the demand for cardiac ablation devices is expected to grow in the United States.
During the forecast period, the United States market is expected to grow at a CAGR of 11.0%, to reach a valuation of USD 4.0 billion by 2033.
Research and Development in the Field of Radiofrequency Ablation Devices to Drive Growth
The increasing research and development activities by prominent companies and medical institutions in the United Kingdom to come up with innovative radiofrequency ablation devices is likely to propel the Europe market in the evaluation period. Many other companies are also aiming to engage in joint ventures and collaborations to compete in the market.
According to a research study published in February 2022 by the National Center for Biotechnology Information (NCBI), a team of researchers at the University College, London, developed an MRI-guided thermoset that enables precision targeting of tumors before the development of ablation. The ongoing research activities to unveil similar other results for boosting advancement in the industry is likely to fuel the market.
The United Kingdom market is projected to grow at a CAGR of 12.6% between 2023 and 2033.
Ablation Machines are to Be Adopted for Cancer Prevention in India
The growing number of initiatives adopted by the Indian government to reduce the cases of cancer and similar other diseases is anticipated to augment the South Asia market in the upcoming years. The National Institute of Cancer Prevention and Research (NICPR), for instance, has launched a program called ‘India against Cancer’ to create awareness about the disease.
As per the NICPR, over 11, 57,294 lakh new cancer patients are registered every year in India and around 2.25 million people are estimated to live with the disease. In 2018, nearly 7, 84,821 deaths occurred due to cancer in the country. These numbers are projected to surge in the future, thereby propelling the need for ablation machines in India.
| Region | North America |
|---|---|
| Country | United States |
| CAGR | 11.0% |
| Market Value (2033) | USD 4.0 Billion |
| Region | Europe |
|---|---|
| Country | United Kingdom |
| CAGR | 12.6% |
| Market Value (2033) | USD 1.1 Billion |
| Region | Asia Pacific |
|---|---|
| Country | China |
| CAGR | 10.5% |
| Market Value (2033) | USD 382.3 Million |
| Region | Asia Pacific |
|---|---|
| Country | South Korea |
| CAGR | 8.6% |
| Market Value (2033) | USD 180.8 Million |
| Region | Asia Pacific |
|---|---|
| Country | Japan |
| CAGR | 9.0% |
| Market Value (2033) | USD 316.8 Million |
Cryoablation Devices are Gaining Immense Popularity
Based on product type, the cryotherapy ablation devices segment is anticipated to remain at the forefront of the global ablation devices market. This growth is attributable to the increasing usage of cryoablation devices to destroy cells by freezing them.
The recovery time after cryosurgery of liver and kidney tumors with the help of cryoablation devices is less than that of the surgical removal of tumors. Overnight stays in hospitals for pain control are not required as the patient is released several hours after the procedure. Cryoablation devices do not cause any apparent post-treatment calcifications and lead to the development of minimal scar tissue during the treatment of fibroadenomas.
The Adoption of Microwave Ablation Machines to Surge among Cancer Patients
By technology, the microwave ablation machine segment is likely to account for 30.2% of the ablation devices market share in 2022, finds FMI. The ability of these machines to deliver image guidance to healthcare professionals for placing a needle through the skin into the liver tumor is anticipated to boost the segment.
The usage of heat to destroy cancer cells with the help of microwave ablation machines is considered to be an effective treatment option for patients who may suffer from difficulties with surgeries. Microwave ablation machines can also be used on those patients whose tumors are less than one and a half inches in terms of diameter.
Rising Prevalence of Liver Cancer to Push the Demand for Thermal Ablation Machines
Based on application, the cancer segment is estimated to lead the ablation devices market in the forecast period. The high demand for minimally invasive alternatives to traditional surgeries for the treatment of lung, liver, kidney, and prostate cancer is expected to push the sales of radiofrequency ablation devices.
According to the Centers for Disease Control and Prevention (CDC), about 9,000 women and 18,600 men die from liver cancer every year in the United States. alone, whereas approximately 10,000 women and 24,500 men suffer from the disease each year in the country. The increasing prevalence of cancer owing to various factors, such as tobacco usage and smoking, unhealthy diet, and inherited cancer genes is set to drive the sales of thermal ablation machines.
Automated Cardiac Ablation Devices are Showcasing High Demand in Hospitals
In terms of function, the automated robotics segment is projected to dominate the global ablation devices market. The high efficiency of automated devices, as compared to traditional ones, is likely to drive the segment in the near future.
By end user, the hospitals' segment is set to procure the lion’s share in the global ablation devices market. This growth is attributable to the increasing preference for hospitals for the treatment of various heart conditions, as well as the availability of technologically advanced medical devices, such as cardiac ablation devices in these settings.
Leading players operating in the global ablation devices market are currently focusing on conducting exhaustive research and development activities to introduce state-of-the-art products to cater to the high demand from healthcare professionals and patients. Meanwhile, some of the other key players are aiming to achieve patents from regulatory bodies for their in-house thermal ablation machines to market them and generate more sales.
Key Market Developments
| Company | Ra Medical Systems |
|---|---|
| Details | Ra Medical Systems is, a designer, developer, and marketer of excimer lasers based in the United States |
| Recent Developments | In February 2022, Ra Medical Systems bagged its new patent for a support catheter from the United States Patent and Trademark Office. It can be used with a small flexible liquid core catheter for laser ablation. This was the company’s tenth patent for the support catheter that is set to be used with the Dabra liquid core ablation catheter. |
| Company | Hologic, Inc. |
|---|---|
| Details | Hologic, Inc., is a medical technology company headquartered in the United States. The company primarily focuses on women’s wellness and manufactures medical equipment for diagnostics as well as surgery |
| Recent Developments | In November 2021, Hologic, Inc., announced that it will be launching NovaSure V5 Global Endometrial Ablation (GEA) device at the 50th Global Congress conducted by the American Association of Gynecologic Laparoscopists (AAGL). The novel device is equipped with EndoForm technology and is designed to accommodate a wide range of anatomical variability and cervical canals, as well as surge the sealing surface. |
| Company | Boston Scientific Corporation |
|---|---|
| Details | Boston Scientific Corporation is an industry leader in biotechnology engineering. It is a multinational manufacturer of advanced medical equipment |
| Recent Developments | In August 2019, Boston Scientific Corporation launched its advanced cryoablation system which is known as ICEfx™. The specialty of this device is that it is a more compact, portable alternative to older versions. |
The market is expected to reach USD 12.6 billion in 2023.
Increasing cancer prevalence and demand for minimally invasive treatments are driving sales.
Boston Scientific, Medtronic, Abbott, Johnson & Johnson are key players in the market.
Laser technology holds a 10.8% share in the ablation devices market.
The ultrasound technology segment accounts for a 15.5% share of the market.
1. Executive Summary | Ablation Devices Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Advanced Ablation Catheters 5.1.1. Cryoablation Catheters 5.1.2. Irrigated tip RF Ablation Catheters 5.1.3. Laser Ablation Catheters 5.2. MRI Guided Neurosurgical Ablation 5.2.1. MRI Guided Laser Therapy System 5.2.2. MRI Guided RF Ablation Systems 5.2.3. MRI Guided Focused Ultrasound Systems 5.2.4. Accessories 5.3. Standard Ablation Catheters 5.4. Bipolar Energy 5.5. Cryotherapy 5.6. Hydrothermal 5.7. Microwave Endometrial 5.8. Standard Ablation Catheters 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technology 6.1. Laser 6.2. Radiofrequency 6.3. Microwave 6.4. Ultrasound 6.5. Others 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 7.1. Cardiovascular 7.2. Cancer 7.3. Urological 7.4. Ophthalmic 7.5. Others 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Functional 8.1. Automated Robotic 8.2. Conventional 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 9.1. Hospitals 9.2. Ambulatory Surgical Centers 9.3. Clinics 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 10.1. North America 10.2. Latin America 10.3. Europe 10.4. East Asia 10.5. South Asia 10.6. Oceania 10.7. Middle East and Africa 11. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 16. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 17. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 18. Key Countries Market Analysis 19. Market Structure Analysis 20. Competition Analysis 20.1. Boston Scientific Corporation 20.2. Medtronic plc 20.3. Abbott Laboratories 20.4. Johnson and Johnson 20.5. AngioDynamics Inc. 20.6. Biotronik SE & Co. KG. 20.7. Japan Lifeline Co. 20.8. CathRx Ltd. 20.9. AtriCure, Inc. 20.10. Hologic, Inc. 21. Assumptions & Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Ablation Devices Market
